A convenient method to concentrate triamcinolone acetonide for intravitreal injection

Retina

Volumn 25, Issue 8, 2005, Pages 1107-1108

  Chin, Hee Seung ^a   Kim, Tae Hwan ^a   Moon, Yeon Sung ^a   Oh, Jung Hyub ^a  

^a Inha University Hospital   (South Korea)

Author keywords

Concentrating method; Intravitreal injection; Triamcinolone acetonide

Indexed keywords

TRIAMCINOLONE ACETONIDE; DRUG; GLUCOCORTICOID;

ARTICLE; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; METHODOLOGY; SEDIMENTATION; SUSPENSION; SYRINGE; CHEMISTRY; HUMAN; INJECTION; VITREOUS BODY;

GLUCOCORTICOIDS; HUMANS; INJECTIONS; PHARMACEUTICAL PREPARATIONS; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 33644873505     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200512000-00026     Document Type: Article

References (6)

1. Martidis A, Duker JS, Greenberg PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927.
2. Jonas JB, Kreissig I, Sofker A, et al. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.
3. Ozkiris A, Evereklioglu C, Erkilic K, Tamcelik N, Mirza E. Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. Eur J Ophthalmol 2004;14:543-549.
4. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 2000;84:1064-1067.
5. Jonas JB, Hayler JK, Sofker A, et al. Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. J Glaucoma 2001;10:284-287.
6. Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF. Intravitreal injection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol 2004;122:218-222.